Rising covid cases unnerve investors

Rising covis cases and tighter measures to stem the spread of the virus are raising fears that the fragile economic recovery will quickly be derailed.

Charts (3)

European bourses start the trading steeply lower as the new week kicks off. Rising covis cases and tighter measures to stem the spread of the virus are raising fears that the fragile economic recovery will quickly be derailed. Fears of a double dip recession are overshadowing upbeat vaccine. Although reports that the UK government is considering reducing quarantine period for covid contacts is helping the FTSE, which hasn’t fallen as steeply as its European peers on the open.

The US and France recorded a record number of coronavirus cases, Spain announced a national curfew and Italy a partial lockdown. Meanwhile in the UK covid cases topped 23,000 with the North East and West seeing the biggest increase in cases. 

Still, risk off is dominating as investors fret over the impact that tighter restrictive measures will have on economic growth. Riskier assets such as stocks are out of favour, whilst flows into safer havens such as the US Dollar are on the rise. 

Not all bad news
News that the British government is considering a shorter isolation period, reduced from 14 days to 7 days for those who have been in contact with someone who tested positive is offering some support to the UK index, which hasn’t sold off as deeply on the open as its European counterparts
News that the Oxford University / AstraZeneca vaccine produces a robust immune response in elderly people, the group at highest risk is broadly being shrugged off by investors. As is news that the vaccine is likely to be distributed to NHS frontline workers and the most vulnerable in December.

A slow start to a busy week
Whilst covid is set to remain a key driver in the market this week, in addition to US elections and US stimulus negotiations, this week is also a key week for corporate releases with UK banks and 4 of the FAANGs reporting, in addition to other big names such as BP, Next, GSK just to mention a few.
Looking ahead it is a relatively slow start to the week with just IFO Business sentiment in focus. 

FTSE Charts
The FTSE trades -0.6%. It trades below its 50, 100 & 200 SMA on the 4 hour chart and below a descending trendline which has been in place since early June – a bearish chart.
Immediate support can be seen at 5760, today’s low prior to 5715, last week’s low. 
Immediate resistance is at 5855 50 SMA prior to 5910/20 region where the 100 & 200 SMA sit. A move above 5970 is needed to negate the current bearish trend.

Build your confidence risk free

More from FTSE 100

Join our live webinars for the latest analysis and trading ideas. Register now

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.